ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ)

$3.55 -0.03 (-0.838%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 83

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) News Sources

NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference

20-04-2026

yahoo.com

Here is Why Eledon Pharmaceuticals (ELDN) is an Unstoppable Stock That Could Double Your Money

20-04-2026

yahoo.com

NewcelX Reports Financial Results for 2025 and Provides Shareholders with Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration with Eledon Pharmaceuticals in 2026

30-04-2026

yahoo.com

EXCLUSIVE: NewcelX Eyes Accelerated 2026 Execution For Diabetes Drug

01-05-2026

benzinga.com

Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Business Highlights

13-05-2026

yahoo.com

Eledon Pharmaceuticals to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at American Transplant Congress

20-05-2026

yahoo.com

NewCelX Ltd. Submits Pre-IND Package to the FDA for NCEL-101 for the Treatment of Type 1 Diabetes

27-05-2026

yahoo.com

Is BillionToOne, Inc. (BLLN) Stock Outpacing Its Medical Peers This Year?

29-05-2026

yahoo.com

Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions

04-06-2026

yahoo.com

Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine

08-06-2026

yahoo.com

ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) Sentiment Trend

0 25 50 75 100 74 93 83 88 90 82 84 92 60 79 20-04-2026 30-04-2026 01-05-2026 13-05-2026 20-05-2026 27-05-2026 29-05-2026 04-06-2026 08-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) FAQs

toggle

What is the current price of ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ)?

The current price of ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) is $3.55.


toggle

ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) absolute price change since previous trading day?

The absolute price change of ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) since the previous trading day is $-0.03.


toggle

ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) percentage price change since previous trading day?

The percentage price change of ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) since the previous trading day is -0.838%.


toggle

What is the most recent average sentiment score for ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ)?

The most recent average sentiment score for ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) is 83 out of 100.


toggle

What is the most recent average sentiment for ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ)?

The most recent sentiment for ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ) is .


SEC-8K** Filing Available For ELEDON PHARMACEUTICALS INC (ELDN:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.